Schedule 13G ownership disclosure

ACADIA Pharmaceuticals Inc

Security class unavailable · CUSIP: 004225108

Event date: 2011-01-10

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
2,496,178
Percent of class
6.4000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001144204-15-021168
Form type
SC 13G/A
Filer
ACADIA PHARMACEUTICALS INC
CIK
CIK 1070494
Filed
Apr 03, 2015
Reporting period
Jan 10, 2011
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub